Gender Differences Seen in Adverse Drug Reactions

Sieta T. de Vries, Ph.D., from the University of Groningen in the Netherlands, and colleagues assessed gender differences in ADRs reported to the national pharmacovigilance center in the Netherlands. To be included, drug-ADR combinations had to be reporte

GSK Receives US Approval of Benlysta for Intravenous Use in Children with Lupus Aged Five Years and Above

GSK Receives US Approval of Benlysta for Intravenous Use in Children with Lupus Aged Five Years and Above London UK, Philadelphia USA April 26, 2019 -- GSK today announced that the US Food and Drug Administration (FDA) has approved, under priority review

FDA Approves Skyrizi FDA Approves Skyrizi (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis

FDA Approves Skyrizi FDA Approves Skyrizi (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis NORTH CHICAGO, Ill., April 23, 2019 /PRNewswire/ -- AbbVie today announced that the U.S. Food and Drug Administration (FDA) approved Skyrizi (risanki

Fennel: A Food Lovers Dream Ingredient

Fennel: A Food Lovers Dream Ingredient FRIDAY, April 19, 2019 -- You might have seen fennel in the produce section of your market without knowing what exactly it was. Fennel is a fragrant bulb that can be a food lovers dream ingredient, because it has a

FDA Halts All Sales of Pelvic Mesh Products Tied to Injuries in Women

FDA Halts All Sales of Pelvic Mesh Products Tied to Injuries in Women TUESDAY, April 16, 2019 -- The U.S. Food and Drug Administration on Tuesday announced a ban on the sale of all pelvic mesh products. "In order for these mesh devices to stay on the

FDA Approves Expanded Monotherapy Label for Merck’s Keytruda (pembrolizumab) for First-Line Treatment of NSCLC